Comparison of an Exoskeleten With an End-effector for Assisted Gait Training in Spinal Cord Injury

Comparison of Exoskeleten Assisted Gait Training With End-effector Assisted Gait Training in Spinal Cord Injury

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03544398

Enrollment

Registered

2018-06-01

Start date

2020-01-01

Completion date

2020-06-30

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Brief summary

Aim is to compare exoskeleton assisted gait training with end-effector assisted gait training in Spinal Cord Rehabilitation

Detailed description

It was planned to evaluate patients aged between 18 and 80 years who will admit to the robotic rehabilitation program due to spinal cord injury. Patients will divide into three groups as Exoskeleton, End-effector and conventional therapy. Exoskeleton and End-effector group will receive robotic therapy 4 days a week besides conventional treatment for 6 weeks. All groups will be evaluated at the start and end of the treatment.

Interventions

OTHERrobot assisted gait training

we use two types of robot assisted gait training and we will compare two groups.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

Clinical diagnosis of spinal cord injury Applying to the hospital for a rehabilitation program

Exclusion criteria

Inadequate body weight (obesity) Severe contractures Bone instability ( nonstable spinal cord fracture, and severe osteoporosis) Circulation problems Cardiac nonconformity Open wounds on the lower extremities or in the body where they will come into contact with the orthosis Uncoordinated, psychotic or aggressive patients Serious cognitive disorders Long-term infusion therapy Hip, knee, ankle arthrodesis Epilepsy Disproportionate limb or vertebrae, such as bone cartilage dysplasia

Design outcomes

Primary

Measure	Time frame	Description
FAC	Change from baseline FAC class to 6th week of therapy	functional ambulational classification scale
6MWT	Change from baseline 6MWT class to 6th week of therapy	6 minute walking test
10MWT	Change from baseline 10MWT class to 6th week of therapy	10 meter walking test

Secondary

Measure	Time frame	Description
ASIA	Change Of ASIA scale from the beginnig to the 6th week of the therapy	ASIA impairment scale
SCIM	Change Of SCIM from the beginnig to the 6th week of the therapy	Spinal cord independence measure

Countries

Turkey (Türkiye)

Contacts

Primary ContactAYLİN SARI

mdaylinsari@gmail.com05058396368

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026